# 1. Financial Performance ## A. Key Figures * **Operating Income:** **₹863.3 Cr** Q4 (+3% YoY) · **₹2,914.8 Cr** FY26 (+7% YoY) * EBITDA: ₹199 Mn Q4 (2.31% margin) · ₹2,102 Mn FY26 (-29% YoY; 7.21% margin) * **Net Profit:** **₹24.3 Cr** Q4 (2.81% margin) · **₹143.2 Cr** FY26 (4.91% margin) * **Roha Segment EBIT Margin:** **<7%** Q4 · **~3%** FY26 ## B. Revenue & Margin Dynamics * **Profitability Headwinds:** Full-year EBITDA saw a sharp double-digit decline and margin contraction, primarily due to input cost pressures and the timing of capitalizations. * **Recovery Strategy:** Management is pursuing price hikes to pass through elevated costs, anticipating a recovery in margins as these negotiations conclude. * **Non-Operating Boost:** Q4 profitability was supported by a spike in other income, attributed to FOREX gains on exports and EPC contract claims. ## C. Capital Allocation & Liquidity * **Project Financing:** Equity for the Oman venture will be funded entirely via internal accruals, maintaining a partner-led funding structure. * **Debt Profile:** Gross debt currently stands at **₹384 Cr**, with a disciplined maintenance CAPEX outlook of **₹30-40 Cr** for FY27. --- # 2. Operating Segments ## A. Key Figures * **Engineering Revenue:** **₹553.9 Cr** (Flat YoY) · **EBIT:** **₹21.5 Cr** * **Chemicals Revenue:** **₹229.7 Cr** (+3% YoY) · **EBIT:** **₹33.4 Cr** * Consumer Products Revenue: ₹1,047 Mn (+34% YoY) · Loss: ₹46 Mn (vs. ₹52 Mn YoY) ## B. Engineering Performance * **Geopolitical Headwinds:** Margins were severely compressed by the **West Asia crisis**, which caused a **₹60 Cr** deferral in high-margin GCC export shipments. * **Mix & Execution Drag:** Profitability was further dampened by a higher proportion of lower-margin domestic sales and slow execution on the **Uttar Pradesh (UP) project**. * **Legacy Project Overhang:** Ongoing challenges with a legacy project continue to impact the segment, with work now expected to extend into **FY27**. ## C. Chemicals Division * **Margin Contraction Drivers:** Segment margins dropped from **25% to 15%**, primarily due to **Roha site expansion expenses** (accounting for 75% of the impact) and rising input costs. * **Operational Disruptions:** Quarterly performance was hindered by logistical delays and shipping disruptions linked to Middle East volatility. * **Strategic Wins:** Secured new contracts for **water treatment specialty chemicals**, diversifying the portfolio beyond the Roha plant's output. ## D. Consumer Products * **Scalability & Growth:** Robust double-digit top-line momentum driven by healthy volume growth and expanding market acceptance. * **Path to Profitability:** Successfully narrowed quarterly losses while maintaining a strategy of reinvesting for long-term platform scalability. ## E. Project Execution * **UP Project Resumption:** Execution of the remaining **₹300 Cr** balance is accelerating following a resumption of government fund inflows and a four-year scheme extension. * **Major Milestones:** Successfully commissioned India’s largest industrial water treatment package at the **IOCL Panipat Refinery**. * **Timeline Updates:** The Sri Lanka project remains on track for **Q2 FY2027** closure, while the legacy UP project is now expected to spill over into the next financial year. --- # 3. Manufacturing & Capacity ## A. Key Figures * **Roha Resin Capacity:** **42,600 cubic meters** fully commissioned * **Utilization Guidance:** **25%** projected for first full year of operation * Investment Horizon: 2-3 years (commenced 2021-22) ## B. Roha Plant Operations & Strategy * **Strategic Export Hub:** The facility was established to bypass capacity constraints at the Ankleshwar plant and specifically target global demand. * **Capitalization Timeline:** Infrastructure was capitalized in **September 2025**, with manufacturing lines following progressively through **March 2026**. * **Profitability Drivers:** While backward integration is ongoing to bolster future margins, current focus remains on ramping up utilization and improving ROCE before further capital commitments. * **Geopolitical Headwinds:** Management maintains its initial utilization guidance despite near-term operational pressures stemming from the **West Asia crisis**. ## C. Global Manufacturing & Competitive Moat * **Supply Chain De-risking:** Commercial production has officially commenced at the new **Dammam, Saudi Arabia** plant to provide localized market access. * **China-Plus-One Advantage:** The company is positioning itself as a rare non-Chinese manufacturer, leveraging domestic cost efficiencies and advanced technology to gain a competitive edge. ## D. Certification & Market Access * **US Market Entry:** Receipt of the **Water Quality Association (WQA)** certification is a critical catalyst, expected to unlock the US drinking water segment and drive revenue growth this fiscal. * **Extended Sales Cycle:** Significant volume off-take from large-scale global customers is subject to a **2-3 year** introduction cycle involving rigorous trials and validations post-commissioning. --- # 4. Order Book & Pipeline ## A. Key Figures * **Engineering Order Book:** **₹2,643.3 Cr** as of March 31, 2026 * **Order Intake Growth:** **40%** increase vs. previous full FY * Oman DBOOT Contract: OMR 73.46 million total value (20-year tenure) [Page 3 of 19] ## B. Backlog Visibility & Reporting * **Execution Timeline:** Robust order intake growth provides healthy revenue visibility, with the majority of projects slated for execution over the current and next fiscal years. * **Reporting Perimeter:** Reported backlog figures are restricted to the **standalone entity**, excluding subsidiaries; notably, this accounting treatment explains the exclusion of the Oman project from quarterly presentations. * **Market Expansion:** Management is focused on progressively capturing market share as global qualification processes conclude across diverse geographies. ## C. International Contracts & Concessions * **Oman Project Commencement:** Execution has begun on the Petroleum Development Oman contract, with O&M revenue expected to start this fiscal and scale significantly by **FY27**. * **Strategic Focus:** Beyond identified headwinds, the segment is prioritized toward securing large-scale, high-margin international contracts to diversify the book. ## D. Customer Metrics & Bidding Activity * **Competitive Landscape:** The company is actively competing for market share against global incumbents including **DuPont, Hydronautics, Toray, and Veolia**. * **Pipeline Dynamics:** Inflows are supported by a healthy enquiry pipeline of medium-sized opportunities, balanced between existing customer volume expansions and new OEM/end-user acquisitions. --- # 5. Strategic Partnerships ## A. Key Figures * **Malawi Project Value:** **USD 18.1 Mn** Water treatment package * **Global Membrane Market Growth:** **10%-plus** CAGR ## B. Technology Transfers * **Strategic Alliance with MANN+HUMMEL:** Established a manufacturing collaboration for ultra-filtration membranes and MBR technology to strengthen the existing portfolio. * **Portfolio Diversification:** Integration of PVDF-type flat sheet membranes complements existing RO and nano-filtration offerings for global distribution. * **Localization & Export Strategy:** Collaboration supports "Make in India" initiatives, positioning the firm to capture high-growth global membrane demand. ## C. Joint Ventures * **African Market Entry:** Secured a significant water treatment package in Malawi via a project-specific joint venture. * **Oman BOT Project:** Execution of the Petroleum Development Oman (PDO) initiative is underway, with financial contributions expected to impact consolidated revenue by fiscal year-end. ## D. M&A Integration * **European Foothold:** The full integration of Portugal-based **MAPRIL** provides local entity status to scale water treatment solutions across the Iberian Peninsula and Southern Europe. ## E. Market Expansion * **Geographic Scaling:** Active distribution of membrane products in the Middle East and Asia-Pacific, with imminent expansion plans for the African and European markets. * **International Footprint:** Executing a focused strategy to deepen customer engagement and grow the international product business across key overseas geographies. --- # 6. Risks & External Factors ## A. Key Figures * **Project Backlog:** **~30%** remaining scope in UP Jal Jeevan Mission ## B. Geopolitical & Logistics Disruptions * **West Asia Crisis Impact:** Regional instability delayed high-value engineering dispatches to **GCC geographies** and disrupted Chemical segment logistics; execution resumed post-quarter following customer clearances. * **Short-term Outlook:** Management expects logistical headwinds to persist into the current quarter, with a full revenue impact assessment slated for the **Q1** update. ## C. Input Costs & Profitability * **Margin Compression:** Profitability was pressured by significant raw material headwinds and facility-specific expenses at **Roha**, specifically regarding **styrene and oleum** costs. * **Mitigation Strategy:** The company has initiated pricing actions to pass through rising input costs to customers, maintaining a target for **PBT break-even** at the plant within the current fiscal year. ## D. Working Capital Management * **Prudent Execution:** Management is intentionally slowing the pace of the UP Jal Jeevan Mission project to align execution strictly with **collections received**, prioritizing working capital health over speed. --- # 7. Guidance & Outlook ## A. Key Figures * **Oman JV CAPEX (51% Stake):** **~$40 Million** Total investment over two years * **FY27 Maintenance CAPEX:** **₹30–40 Cr** Estimated range * **Membrane Market Growth:** **>10%** Global annual rate ## B. Revenue & Profitability Outlook * **Revenue Recovery:** Management expects to recoup deferred resins business revenue previously lost to logistics challenges. * **FY27 Visibility:** Specific sales and margin guidance is deferred until H2 due to **RM inflation** and **geopolitical volatility** in West Asia. * **Consumer Segment Trajectory:** Anticipated growth to continue on a high base, with a strategic pivot toward reaching **break-even or low single-digit margins**. ## C. CAPEX & Strategic Investment * **Oman Expansion:** Significant capital commitment of **USD 40 million** for the IE & Co. LLC joint venture, to be funded via a debt-equity mix. * **Asset Maintenance:** Near-term spending is restricted to routine expenditures, with no major domestic plant expansions currently planned. ## D. Long-Term Growth Drivers * **International Expansion:** Heavy investment continues in overseas markets to capture untapped potential despite dynamic macro headwinds. * **Membrane Applications:** Long-term growth underpinned by global demand for wastewater treatment, recycling, and brackish water solutions.